For patients experiencing ischemic stroke — the leading cause of disability in the U.S. — time to treatment is critically important for avoiding irreversible brain damage.
A study by researchers at Overlook Medical Center and Atlantic Health System, published by the journal Stroke, shows that patients evaluated in ambulances while in-transit to the hospital, could be treated with the brain saving drug alteplase 13 minutes faster once in the Emergency Department — referred to as door-to-needle, or DTN, time — than patients not evaluated with in-transit telestroke (ITTS).
The first-of-its-kind study assessed 89 presumptive stroke patients in ambulances over 15 months (Jan. 2015 – Mar. 2016). Atlantic Health System paramedics responding to neurological emergencies used an InTouch Xpress device – a portable unit with a high-definition camera, microphone and screen – allowing video communication with a stroke neurologist who performed a neurological evaluation of the patient while in-transit to the emergency department (ED).
Filed under: Uncategorized |